Skip to content

Author

Shi-Mei Shi

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Research Progress and Challenges in the Use of TROP2-Targeted Antibody-Drug Conjugates for the Treatment of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC), characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression, has long been associated with limited treatment targets, a high risk of recurrence and metastasis, and a poor prognosis. In recent ye...

Shi-Mei Shi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.